Vemurafenib + Fotemustine to Treat Advanced Melanoma Patients With V600BRAF Mutation Recurred While on Vemurafenib
Clinical trial NCT01983124 · COMPLETED
Trial details
- NCT number
- NCT01983124
- Sponsor
- Paola Queirolo
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-02-01
- Primary completion
- 2014-04-01
- Enrollment
- 31
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.